C N Parker
Overview
Explore the profile of C N Parker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finlayson K, Parker C, Miller C, Edwards H, Campbell J
Phlebology
. 2021 Dec;
37(3):206-215.
PMID: 34965772
Aim: To identify clinical, medical and psychosocial predictors of venous leg ulcer recurrence within 12 months of healing. Methods: A multi-site study was conducted in Australia in community and hospital...
2.
Parker C, Harvey T, Johnston S, MacAndrew M
Nurse Educ Today
. 2020 Nov;
96:104639.
PMID: 33142221
Background: Advances in healthcare have contributed to population longevity with many older adults living with complex comorbidities, including those in residential aged care facilities (RACFs). Nursing staff require knowledge of...
3.
Parker C, Finlayson K, Edwards H
J Wound Care
. 2016 Nov;
25(11):626-634.
PMID: 27827277
Objective: Chronic wounds are costly and affect approximately 1-2% of the population. Venous disease is responsible for about 60% of all chronic leg ulcers and these ulcers can be debilitating,...
4.
Agarinis C, Orsini V, Megel P, Abraham Y, Yang H, Mickanin C, et al.
J Biomol Screen
. 2015 Dec;
21(3):269-76.
PMID: 26637552
The Yap-Hippo pathway has a significant role in regulating cell proliferation and growth, thus controlling organ size and regeneration. The Hippo pathway regulates two highly conserved, transcription coactivators, YAP and...
5.
Parker C, Finlayson K, Shuter P, Edwards H
Int J Clin Pract
. 2015 Aug;
69(9):1029-30.
PMID: 26311330
No abstract available.
6.
Parker C, Finlayson K, Shuter P, Edwards H
Int J Clin Pract
. 2015 Apr;
69(9):967-77.
PMID: 25831965
Background: Chronic leg ulcers, remaining unhealed after 4-6 weeks, affect 1-3% of the population, with treatment costly and health service resource intensive. Venous disease contributes to approximately 70% of all...
7.
Evans J, Turner B, Bowen S, Ho A, Sarver R, Benson E, et al.
Bioorg Med Chem Lett
. 2003 Mar;
13(6):993-6.
PMID: 12643896
Screening for inhibitors of bacterial protein synthesis Initiation Factor 2 (IF2) binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA((fMet))) identified a series of aminoglycosides, that included amikacin and kanamycin A1, as inhibitors of...
8.
Wilson L, Morris T, Wu Q, Renick P, Parker C, Davis M, et al.
Bioorg Med Chem Lett
. 2001 May;
11(9):1149-52.
PMID: 11354364
An effort to identify novel inhibitors of peptidoglycan synthesis with antibacterial activity resulted in the discovery of a series of biaryl urea-based antibacterial agents through isolation of a by-product from...
9.
Roychoudhury S, Blondelle S, Collins S, Davis M, McKeever H, Houghten R, et al.
Mol Divers
. 2000 Mar;
4(3):173-82.
PMID: 10729902
Bacterial resistance to antibiotics is emerging as a major concern to the medical community. The appearance of several antibiotic-resistant strains, including multidrug-resistant Staphylococcus aureus, raises the prospect that infections by...
10.
Stanton D, Morris T, Roychoudhury S, Parker C
J Chem Inf Comput Sci
. 1999 Feb;
39(1):21-7.
PMID: 9987851
High throughput screening (HTS) programs based on diverse collections of compounds can rapidly identify leads for potential drug candidates. In cases where the compound collection is truly diverse, one may...